Workflow
维力医疗(603309) - 2024 Q1 - 季度财报
Well LeadWell Lead(SH:603309)2024-04-18 10:54

Financial Performance - Total revenue for the first quarter of 2024 was CNY 309,185,113.48, representing a decrease of 14.49% compared to the same period last year [24]. - Net profit attributable to shareholders of the listed company was CNY 50,255,959.75, down 3.54% year-on-year [24]. - Net profit excluding non-recurring gains and losses was CNY 47,011,106.82, a decrease of 0.68% compared to the previous year [24]. - Basic earnings per share for the first quarter was CNY 0.17, down 5.56% from the same period last year [24]. - Diluted earnings per share also stood at CNY 0.17, a decrease of 5.56% year-on-year [24]. - Operating profit for Q1 2024 was approximately ¥62.94 million, a decline of 12.4% from ¥72.32 million in Q1 2023 [39]. - Total operating costs for Q1 2024 were approximately ¥248.11 million, down 15.5% from ¥293.47 million in Q1 2023 [39]. Cash Flow and Liquidity - In Q1 2024, the net cash flow from operating activities decreased by 43.25% due to increased cash payments for goods and services [10]. - Net cash flow from operating activities was CNY 38,407,488.30, reflecting a significant decline of 43.25% year-on-year [24]. - The net cash inflow from operating activities for Q1 2024 was ¥38,407,488.30, a decrease from ¥67,675,594.49 in the same period last year [35]. - The company reported cash and cash equivalents of RMB 473,369,439.88, compared to RMB 302,874,372.11 in the previous year, reflecting a year-over-year growth of approximately 56.2% [13]. - Cash and cash equivalents at the end of Q1 2024 totaled approximately ¥473.36 million, an increase from ¥316.40 million at the end of Q1 2023 [42]. - The company reported a net increase in cash and cash equivalents of approximately ¥170.50 million in Q1 2024, compared to a decrease of ¥75.04 million in Q1 2023 [42]. Assets and Liabilities - As of March 31, 2024, total current assets amounted to RMB 1,017,595,592.54, up from RMB 817,389,300.85 at the end of 2023, indicating a significant increase in liquidity [13]. - Total assets increased to CNY 2,837,303,570.84, up 8.91% from the end of the previous year [24]. - The total liabilities increased to ¥947,839,868.90 from ¥768,368,160.46, indicating a significant rise in financial obligations [32]. - The total equity of the company reached ¥1,889,463,701.94, up from ¥1,836,913,273.34, reflecting a positive trend in shareholder equity [32]. - The equity attributable to shareholders of the listed company increased to ¥1,867,351,094.79, representing a growth of 2.77% compared to ¥1,817,095,135.04 [25]. Shareholder Information - The top shareholder, Gaobo Investment (Hong Kong) Co., Ltd., holds 31.39% of the shares, totaling 92,019,200 shares [10]. - The total number of ordinary shareholders at the end of the reporting period was 18,342 [10]. - There are no significant changes in the top ten shareholders compared to the previous period [10]. Research and Development - Research and development expenses for Q1 2024 were approximately ¥20.48 million, an increase of 14.0% compared to ¥17.97 million in Q1 2023 [39]. - The company did not report any new product launches or technological advancements during this quarter [10]. Other Financial Metrics - The company reported a government subsidy income of ¥1,653,982.95, contributing positively to the financial results [25]. - The company recorded a non-operating income of ¥239,585.34, which is part of the non-recurring gains [25]. - Financial expenses for Q1 2024 were approximately ¥259.15 thousand, a significant decrease from ¥3.68 million in Q1 2023 [39]. - Tax expenses for Q1 2024 were approximately ¥10.35 million, down 28.5% from ¥14.46 million in Q1 2023 [39]. - The net cash outflow from investment activities was ¥140,189,372.53, an improvement compared to a net outflow of ¥185,035,220.76 in the previous year [35]. - Long-term equity investments amounted to CNY 109,746,848.23, showing a slight decrease from the previous period [24]. - Long-term borrowings increased to ¥306,110,114.97 from ¥258,650,779.97, indicating a rise in long-term financial commitments [32]. - The company’s retained earnings rose to ¥846,510,951.46 from ¥796,254,991.71, showing an increase in accumulated profits [32].